OPXS: Hold with a $9.27 price target

Borrowing is lower relative to earnings, but the profit margin narrowed.

Target for 2027-09-18: $9.27 USD, -9.2% versus the $10.21 weekly close on 2026-09-11. Price return only; dividends, fees and tax excluded.

Over 1 year (2025-09-12 to 2026-09-11), price changed -14.1% and trailing EPS changed -26.3%. A wider gap changes the earnings multiple; it does not establish fair value.

Net debt / EBITDA: -0.8× for OPXS, against 1.7× across 12 comparable peers.

The estimate for the period ending 2026-09-30 changed +1.3% over 30 days. Coverage is 1 analysts.

The latest quarterly operating margin was 14.3%, -2.9 percentage points from a year earlier. The full report separates sales growth from margin changes.

Across 3 completed quarters since 2025-09-30, net income was 2.9m versus 4.1m in the matching prior-year periods (USD). Check whether the latest quarter changes that direction.

Compare the next results with the trailing margin of 13.2% and the annual-history median of 10.9%. A historical median is context, not a forecast.

The latest quarterly margin changed -2.9 percentage points from a year earlier. Check sales volumes, pricing and unusual gains in the next filing.

Recheck the valuation gap alongside profitability and growth after new results. A discount alone does not establish value.

Starting annual sales growth: 0.64%.

Net profit margin: 10.43%.

Review recorded on 2026-09-18. This is a dated summary of an automated company valuation. The full report includes the financial evidence, alternative scenarios and review history. Consult the latest report before using an earlier target. Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.